Regencell Bioscience Holdings Ltd (RGC) Stock Price, Trades & News

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Financial Strength

7/10

Name	Current	Vs Industry	Vs History
Cash-To-Debt	8.99
Equity-to-Asset	0.41
Debt-to-Equity	0.45
Debt-to-EBITDA	-0.08
Interest Coverage	N/A	N/A	N/A
Piotroski F-Score	2/9	0 1 2 3 4 5 6 7 8 9
WACC vs ROIC		WACC ROIC

Growth Rank

	Name	Current	Vs Industry		Vs History
	3-Year EBITDA Growth Rate	20.6
	3-Year EPS without NRI Growth Rate	22.4
	3-Year FCF Growth Rate	16.4
	3-Year Book Growth Rate	-34.1

Momentum Rank

8/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	6.01
	9-Day RSI	9.7
	14-Day RSI	14.94
	3-1 Month Momentum %	-4.29
	6-1 Month Momentum %	14.89
	12-1 Month Momentum %	20.41

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Shareholder Yield %	-0.01

Profitability Rank

1/10

	Name	Current	Vs Industry		Vs History
	ROE %	-165.29
	ROA %	-130.15
	ROIC %	-183.53
	3-Year ROIIC %	-469.84
	ROC (Joel Greenblatt) %	-220.51
	ROCE %	-137.29
	Moat Score	2
	Tariff Resilience Score	3

GF Value Rank

	Name	Current	Vs Industry		Vs History
	PB Ratio	3177.5
	EV-to-EBIT	-440.01
	EV-to-EBITDA	-440.01
	EV-to-FCF	-960.55
	Price-to-Net-Current-Asset-Value	635.5
	Price-to-Net-Cash	635.5
	Earnings Yield (Greenblatt) %	-0.23
	FCF Yield %	-0.1

GF Value™

RGC

Warning Signs

Warning! GuruFocus detected 2 Severe warning signs with RGC. Try a 7-Day Free Trial to check it out.

Regencell Bioscience Holdings Ltd Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Regencell Bioscience Holdings Ltd Stock Events

Financials Calendars

Event	Date	Price ($)
Annual report for 2026	2026-10-30	In 123 days
General meeting for 2025	2026-06-30	In 1 day
Second quarter earnings results for 2026	2026-06-30	In 1 day
Annual report for 2025	2025-10-31	16.35 (+0.74%)
38:1 Stock Split	2025-06-16	15.66 (-5.22%)
Annual report for 2024	2024-10-25	0.12 (-1.51%)

Show

Entries

Guru Commentaries on NAS:RGC

No articles.

Press Release

	Subject	Date
	Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm	2026-06-23
	Regencell Deadline Today: Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights	2026-06-23
	RGC Shareholder Alert: June 23, 2026 Lead Plaintiff Deadline in Regencell Bioscience Holdings Limited Securities Class Action - Contact The Gross Law Firm	2026-06-23
	RGC FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026	2026-06-23
	RGC Deadline: RGC Investors with Losses in Excess of $100K Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit	2026-06-23
	Deadline Soon: Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit	2026-06-22
	RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026	2026-06-19
	SueWallSt Reminds Regencell Bioscience Holdings Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 23, 2026 - RGC	2026-06-18
	Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC	2026-06-18
	RGC Deadline: RGC Investors with Losses in Excess of $100K Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit	2026-06-17

10/Page

Articles on Regencell Bioscience Holdings Ltd

No articles.

Headlines

Jun 13, 2026

RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026

Benzinga • 7:20am

Jun 05, 2026

Robbins LLP Reminds RGC Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Regencell Bioscience Holdings Limited

Benzinga • 1:12pm

Jun 04, 2026

Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role

Benzinga • 3:39pm

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.